Explorer les evidences

19 %Occult hepatitis B virus (OBI) patients comprised 19.0% of HBsAg-negative, anti-HBc-positive patients.

Kenyahépatite Bpublié 2021PloS onePubMeddocument de 7 observations

1 %Mixed populations accounted for 1% of hepatitis B virus infections in Kenya.

Kenyahépatite Bpublié 2023PLOS global public healtheurope_pmcdocument de 8 observations

92 %For hepatitis B virus (HBV) vaccine, 92% of control subjects were protected compared to 71% of MVA.HIVA subjects (p=0.05).

Kenyahépatite Bpublié 2014Vaccineeurope_pmcdocument de 10 observations

5,2 %HBV prevalence was 5.2% among participants aged 25–29 years.

Kenyahépatite Bpublié 2023PloS onePubMeddocument de 15 observations

1 %D/E recombinants accounted for 1% of hepatitis B virus infections in Kenya.

Kenyahépatite Bpublié 2023PLOS global public healtheurope_pmcdocument de 8 observations

8,2 %The prevalence of Hepatitis B virus infection in Human Immunodeficiency Virus-infected individuals in Kenya was 8.2%.

Kenyahépatite Bpublié 2023Frontiers in public healthPubMeddocument de 6 observations

After six months of antiretroviral therapy follow-up, there was a significant increase in CD4 count for both HIV mono-infected and HIV/HBV co-infected groups at p<0.001.

Kenyahépatite B · VIH/sidapublié 2021Pan African Medical JournalOpenAlexdocument de 10 observations

18,7 %Of the 166 HBsAg-negative samples tested, 31 (18.7%) were HBV DNA positive, indicating occult hepatitis B infection.

Kenyahépatite Bpublié 2020PloS onePubMeddocument de 2 observations

4,73 %Hepatitis B virus (HBV) accounted for 4.73% of discarded blood units due to transfusion transmissible infections at the Kwale Satellite Blood Transfusion Centre in Kenya from 2018 to 2022.

Kenyahépatite Bobservé 2018-2022publié 2024BMC public healthPubMeddocument de 7 observations

6,8 %HBV prevalence was 6.8% (95% CI: 1.7–11.8%) among persons in polygamous marriages in Kenya.

Kenyahépatite Bobservé 2018publié 2024PloS onePubMeddocument de 10 observations

0,5 %Among 1265 participants with complete data on HBsAg and HBcAb-Total, 0.5% had acute HBV infection.

Kenyahépatite Bpublié 2023PloS onePubMeddocument de 15 observations

0,35 aorThe odds of never being HBV infected were lower among older individuals aged ≥30 years (adjusted odds ratio 0.35).

Kenyahépatite Bpublié 2023PloS onePubMeddocument de 15 observations

1 731 copies/mlAt the end of the study, the mean viral load for HIV/HBV co-infected individuals was 1731 copies/ml.

Kenyahépatite B · VIH/sidapublié 2021Pan African Medical JournalOpenAlexdocument de 10 observations

3,9 %HBV prevalence was 3.9% among males and 2.8% among females.

Kenyahépatite Bpublié 2023PloS onePubMeddocument de 15 observations

11,76 %Patients with elevated liver enzyme ALT among HIV/HBV co infected persons was 11.76%.

Kenyahépatite B · VIH/sidapublié 2012The African Journal of Pharmacology and TherapeuticsOpenAlexdocument de 2 observations

19,5 %Among 577 pregnant women attending selected Primary Health Care facilities in Kenya, 19.5% had been tested for hepatitis B virus (HBV).

Kenyahépatite Bpublié 2024Frontiers in public healthPubMeddocument de 15 observations

1,1 %Testing using the four-tests panel yielded a positivity rate of 1.1% for hepatitis B virus (HBV) among pregnant women in selected Primary Health Care facilities in Kenya.

Kenyahépatite Bpublié 2024Frontiers in public healthPubMeddocument de 15 observations

3,4 %HBV prevalence was 3.4% among screened participants in Kenya and Uganda.

Kenya · Ougandahépatite Bpublié 2023PloS onePubMeddocument de 15 observations

8,3 %Out of 577 pregnant women attending selected Primary Health Care facilities in Kenya, only 8.3% had test results for all four infections (HIV, syphilis, hepatitis B virus, and malaria) available.

Kenyahépatite B · paludisme · syphilis · VIH/sidapublié 2024Frontiers in public healthPubMeddocument de 15 observations

6,5 %HBV prevalence was 6.5% among those in informal low risk jobs.

Kenyahépatite Bpublié 2023PloS onePubMeddocument de 15 observations

3,2 %Among 1265 participants with complete data on HBsAg and HBcAb-Total, 3.2% had chronic HBV infection.

Kenyahépatite Bpublié 2023PloS onePubMeddocument de 15 observations

38 %Once enrolled, principle reasons for exclusion from analysis included detection of Hepatitis B surface antigen (106/280, 38%) and antibodies against Hepatitis C (95, 34%).

Kenyahépatite B · hépatite Cpublié 2008PloS oneeurope_pmcdocument de 4 observations

5,3 %HBV prevalence was 5.3% (95% CI: 2.8–7.7%) among persons in the lowest wealth quintile in Kenya.

Kenyahépatite Bobservé 2018publié 2024PloS onePubMeddocument de 10 observations

1,85 %The prevalence of hepatitis B among blood donations was 1.85%.

Kenyahépatite Bpublié 2026Global health, epidemiology and genomicsPubMeddocument de 3 observations

91,7 %The use of the four-tests panel improved data management for the four infections by 91.7% in selected Primary Health Care facilities in Kenya.

Kenyahépatite B · paludisme · syphilis · VIH/sidapublié 2024Frontiers in public healthPubMeddocument de 15 observations